A DOUBLE-BLINDED, RANDOMISED, FOUR-PERIOD CROSSOVER EUGLYCEMIC CLAMP TRIAL INVESTIGATING THE DOSE-RESPONSE AND DOSE-EXPOSURE RELATIONSHIP OF BIOCHAPERONE INSULIN LISPRO IN THREE DIFFERENT DOSES IN SUBJECTS WITH TYPE 1 DIABETES: